ProShare Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,976
| Closed | -$614K | – | 2028 |
|
|
2023
Q4 | $614K | Buy |
25,976
+6,817
| +36% | +$161K | ﹤0.01% | 930 |
|
|
2023
Q3 | $286K | Buy |
19,159
+93
| +0.5% | +$1.39K | ﹤0.01% | 1235 |
|
|
2023
Q2 | $209K | Buy |
+19,066
| New | +$209K | ﹤0.01% | 1514 |
|
|
2022
Q2 | – | Sell |
-24,721
| Closed | -$76K | – | 2202 |
|
|
2022
Q1 | $76K | Sell |
24,721
-2,344
| -9% | -$7.21K | ﹤0.01% | 2073 |
|
|
2021
Q4 | $92K | Buy |
27,065
+3,443
| +15% | +$11.7K | ﹤0.01% | 2215 |
|
|
2021
Q3 | $86K | Sell |
23,622
-6,756
| -22% | -$24.6K | ﹤0.01% | 1929 |
|
|
2021
Q2 | $132K | Buy |
30,378
+2,339
| +8% | +$10.2K | ﹤0.01% | 2245 |
|
|
2021
Q1 | $127K | Buy |
28,039
+2,058
| +8% | +$9.32K | ﹤0.01% | 2135 |
|
|
2020
Q4 | $149K | Buy |
25,981
+6,389
| +33% | +$36.6K | ﹤0.01% | 1922 |
|
|
2020
Q3 | $142K | Sell |
19,592
-827
| -4% | -$5.99K | ﹤0.01% | 1481 |
|
|
2020
Q2 | $71K | Buy |
20,419
+6,934
| +51% | +$24.1K | ﹤0.01% | 1608 |
|
|
2020
Q1 | $20K | Sell |
13,485
-10,710
| -44% | -$15.9K | ﹤0.01% | 1136 |
|
|
2019
Q4 | $47K | Sell |
24,195
-2,249
| -9% | -$4.37K | ﹤0.01% | 1752 |
|
|
2019
Q3 | $135K | Buy |
26,444
+84
| +0.3% | +$429 | ﹤0.01% | 1504 |
|
|
2019
Q2 | $189K | Sell |
26,360
-322
| -1% | -$2.31K | ﹤0.01% | 1451 |
|
|
2019
Q1 | $354K | Buy |
26,682
+329
| +1% | +$4.37K | ﹤0.01% | 1177 |
|
|
2018
Q4 | $207K | Buy |
+26,353
| New | +$207K | ﹤0.01% | 1358 |
|